Attached files
Exhibit
32.2
CERTIFICATION
OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. 1350, AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF
2002
In connection with
the Quarterly Report on Form 10-Q of Edesa Biotech, Inc. (the
“Company”) for the quarter ended June 30, 2020, as filed with the Securities
and Exchange Commission on the date hereof (the
“Report”), I, Kathi Niffenegger, Chief Financial
Officer of the Company, certify, pursuant to 18 U.S.C. Section
1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act
of 2002, that:
|
1.
|
The Report fully
complies with the requirements of section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
|
|
2.
|
The information
contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the
Company.
|
Date: August 12,
2020
|
By:
|
/s/ Kathi
Niffenegger
|
|
|
Kathi
Niffenegger
|
|
|
Chief Financial
Officer
|
|
|
(Principal
Financial Officer)
|